Back to Home
Video

Module 3: Liquid Biopsies and Novel Modalities in GI Cancer

Release Date

May 22, 2026

Expiration Date

May 23, 2027

Credits

1.75 CME, NCPD

Specialties

Gastrointestinal Cancer, Medical Oncology+2 more

Activity Overview

This educational activity is an archive of the live conference held on April 11, 2026.

Target Audience

This educational activity is directed toward medical oncologists, surgical oncologists, radiation oncologists, gastroenterologists, and hepatologists who are interested in the treatment of GI cancers. Nurse practitioners, physician assistants, nurses, pathologists, pharmacists, and other health care professionals involved in the treatment and management of patients with GI cancers are invited to attend.

Learning Objectives

  • Evaluate the clinical impact of recent findings from landmark trials of emerging treatment strategies for the management of GI cancers
  • Apply evolving evidence into individualized, multidisciplinary care strategies to improve outcomes for patients with GI cancers
  • Implement best practices for preventing, recognizing, and managing TRAEs associated with novel therapies used for the management of GI cancers
      Module 3: Liquid Biopsies and Novel Modalities in GI Cancer

      GET STARTED WITH THIS PROGRAM:

      Register now to gain access to this program.

      Create AccountAlready Registered? Login Here

      Accreditation/Credit Designation

      Physicians’ Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

      Physicians’ Education Resource®, LLC designates this enduring material for a maximum of 1.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

      Physicians’ Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669, for 1.75 Contact Hour.

      Acknowledgment of Commercial Support

      This activity is supported by an educational grants from Daiichi Sankyo, Inc; Exact Sciences Corporation; Exelixis; and Partner Therapeutics.

      Follow Us on Social Media!

      Related Content

      Course

      Module 3: Liquid Biopsies and Novel Modalities in GI Cancer

      Create Account